Klaus Langer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Beilstein journal of nanotechnology

International journal of molecular sciences

Journal of patient safety

International journal of clinical pharmacy

Westfalische Wilhelms-Universität Munster

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Westfalische Wilhelms-Universität Munster Mar 01 2009

Germany

Professor :: Institute of Pharmaceutical Technology and Biopharmacy

Publications

Sarah Hardebeck, Sebastian Schreiber, Annika Adick, Klaus Langer, Joachim Jose
A FRET-Based Assay for the Identification of PCNA Inhibitors. International journal of molecular sciences 24 (14) (2023)
Anja Feldmann, Yvonne Nitschke, Franziska Linß, Dennis Mulac, Sina Stücker, Jessica Bertrand, Insa Buers, Klaus Langer, Frank Rutsch
Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles. International journal of molecular sciences 24 (22) (2023)
Johanna Weitzel, Klaus Langer, Olaf Rose
Effects of Generic Exchange of Levodopa Medication in Patients With Parkinson Disease. Journal of patient safety 18 (7) (2022)
Sarah Hester, Katja Bettina Ferenz, Susanne Eitner, Klaus Langer
Development of a Lyophilization Process for Long-Term Storage of Albumin-Based Perfluorodecalin-Filled Artificial Oxygen Carriers. Pharmaceutics 13 (4) (2021)
Johanna Weitzel, Susanne Erzkamp, Klaus Langer, Olaf Rose
Effects of generic exchange of solid oral dosage forms in neurological disorders: a systematic review. International journal of clinical pharmacy 42 (2) (2020)
Hannah Onafuye, Sebastian Pieper, Dennis Mulac, Jindrich Cinatl, Mark N Wass, Klaus Langer, Martin Michaelis
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells. Beilstein journal of nanotechnology 10 (2019)
Sebastian Pieper, Hannah Onafuye, Dennis Mulac, Jindrich Cinatl, Mark N Wass, Martin Michaelis, Klaus Langer
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity. Beilstein journal of nanotechnology 10 (2019)
Njogu M Kimani, Solveig Backhaus, Josphat C Matasyoh, Marcel Kaiser, Fabian C Herrmann, Thomas Jürgen Schmidt, Klaus Langer
Preparation of Sesquiterpene Lactone-Loaded PLA Nanoparticles and Evaluation of Their Antitrypanosomal Activity. Molecules (Basel, Switzerland) 24 (11) (2019)
Katrin Partikel, Robin Korte, Dennis Mulac, Hans-Ulrich Humpf, Klaus Langer
Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles. Beilstein journal of nanotechnology 10 (2019)

Klaus Langer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Klaus Langer